[NBY] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
10-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- 56.67%
YoY- 35.39%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 3,984 1,789 2,794 4,122 2,663 1,008 123 78.44%
PBT -4,481 -2,499 -1,588 -1,738 -2,688 -4,881 -2,932 7.31%
Tax 1 2 1 -15 2 6 10 -31.84%
NP -4,482 -2,530 -1,589 -1,738 -2,690 -4,887 -2,942 7.26%
Tax Rate - - - - - - - -
Total Cost 8,466 4,319 4,383 5,860 5,353 5,895 3,065 18.43%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin -112.50 -141.42 -56.87 -42.16 -101.01 -484.82 -2,391.87 -39.89%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -5.16 -4.76 -3.25 -3.97 -12.71 -64.47 -52.50 -32.04%
EPS Diluted -5.16 -4.76 -3.22 -3.97 -12.71 -64.47 -50.71 -31.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.